BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 16777114)

  • 1. Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism.
    Henneman P; Schaap FG; Havekes LM; Rensen PC; Frants RR; van Tol A; Hattori H; Smelt AH; van Dijk KW
    Atherosclerosis; 2007 Jul; 193(1):129-34. PubMed ID: 16777114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between the distribution of plasma HDL subclasses and the polymorphisms of APOA5 in hypertriglyceridemia.
    Long S; Chen Z; Han Y; Christopher DM; Zhang C; Yang Y; Tian Y
    Clin Biochem; 2013 Jun; 46(9):733-9. PubMed ID: 23499587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The functional interaction on in vitro gene expression of APOA5 SNPs, defining haplotype APOA52, and their paradoxical association with plasma triglyceride but not plasma apoAV levels.
    Palmen J; Smith AJ; Dorfmeister B; Putt W; Humphries SE; Talmud PJ
    Biochim Biophys Acta; 2008; 1782(7-8):447-52. PubMed ID: 18395529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strong linkage disequilibrium and association of -1131T>C and c.553G>T polymorphisms of the apolipoprotein A5 gene with hypertriglyceridemia in a Japanese population.
    Matsunaga A; Arishima H; Niimura H; Zhang B; Uehara Y; Ohwaki K; Morita M; Hayashida K; Saku K
    Circ J; 2007 May; 71(5):746-52. PubMed ID: 17457003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo characterization of human APOA5 haplotypes.
    Ahituv N; Akiyama J; Chapman-Helleboid A; Fruchart J; Pennacchio LA
    Genomics; 2007 Dec; 90(6):674-9. PubMed ID: 17936576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of APOA5 -1131T>C and S19W gene polymorphisms with both mild hypertriglyceridemia and hyperchylomicronemia in type 2 diabetic patients.
    Charriere S; Bernard S; Aqallal M; Merlin M; Billon S; Perrot L; Le Coquil E; Sassolas A; Moulin P; Marcais C
    Clin Chim Acta; 2008 Aug; 394(1-2):99-103. PubMed ID: 18468520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient lowering of triglyceride levels in mice by human apoAV protein variants associated with hypertriglyceridemia.
    Vaessen SF; Sierts JA; Kuivenhoven JA; Schaap FG
    Biochem Biophys Res Commun; 2009 Feb; 379(2):542-6. PubMed ID: 19121291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-study.
    Ariza MJ; Sánchez-Chaparro MA; Barón FJ; Hornos AM; Calvo-Bonacho E; Rioja J; Valdivielso P; Gelpi JA; González-Santos P
    BMC Med Genet; 2010 Apr; 11():66. PubMed ID: 20429872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemia.
    Wang J; Ban MR; Kennedy BA; Anand S; Yusuf S; Huff MW; Pollex RL; Hegele RA
    Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):730-7. PubMed ID: 18779834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study.
    Martinelli N; Trabetti E; Bassi A; Girelli D; Friso S; Pizzolo F; Sandri M; Malerba G; Pignatti PF; Corrocher R; Olivieri O
    Atherosclerosis; 2007 Apr; 191(2):409-17. PubMed ID: 16682041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between APOA5 -1131T>C and APOE polymorphisms and their association with severe hypertriglyceridemia.
    Sousa MO; Alía P; Pintó X; Corbella E; Navarro MA
    Clin Chim Acta; 2008 Sep; 395(1-2):68-71. PubMed ID: 18549811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two novel rare variants of APOA5 gene found in subjects with severe hypertriglyceridemia.
    Pisciotta L; Fresa R; Bellocchio A; Guido V; Priore Oliva C; Calandra S; Bertolini S
    Clin Chim Acta; 2011 Nov; 412(23-24):2194-8. PubMed ID: 21846464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA polymorphisms and haplotypes of apolipoprotein A5's attribution to the plasma triglyceride levels in Koreans.
    Choi JR; Nam CM; Kang DR; Eom SM; Lee HJ; Park CM; Im JW; Jang Y
    Yonsei Med J; 2007 Aug; 48(4):609-18. PubMed ID: 17722232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SNPs at the APOA5 gene account for the strong association with hypertriglyceridaemia at the APOA5/A4/C3/A1 locus on chromosome 11q23 in the Northern Irish population.
    Wright WT; Young IS; Nicholls DP; Patterson C; Lyttle K; Graham CA
    Atherosclerosis; 2006 Apr; 185(2):353-60. PubMed ID: 16125709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOA5-1131T>C genotype effects on apolipoprotein A5 and triglyceride levels in response to dietary intervention and regular exercise (DIRE) in hypertriglyceridemic subjects.
    Jang Y; Chae JS; Kim OY; Park HJ; Kim JY; Paik JK; Lee SH; Lee JH
    Atherosclerosis; 2010 Aug; 211(2):512-9. PubMed ID: 20392444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare APOA5 mutations--clinical consequences, metabolic and functional effects: an ENID review.
    Talmud PJ
    Atherosclerosis; 2007 Oct; 194(2):287-92. PubMed ID: 17222847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of apolipoprotein A5 (APOA5) polymorphisms on serum triglyceride levels in schizophrenic patients under long-term atypical antipsychotic treatment.
    Hong CJ; Chen TT; Bai YM; Liou YJ; Tsai SJ
    World J Biol Psychiatry; 2012 Jan; 13(1):22-9. PubMed ID: 21375366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation screening of the APOA5 gene in subjects with coronary artery disease.
    Soufi M; Sattler AM; Kurt B; Schaefer JR
    J Investig Med; 2012 Oct; 60(7):1015-9. PubMed ID: 22914599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The apolipoprotein A5 (APOA5) gene predisposes Caucasian children to elevated triglycerides and vitamin E (Four Provinces Study).
    Guardiola M; Ribalta J; Gómez-Coronado D; Lasunción MA; de Oya M; Garcés C
    Atherosclerosis; 2010 Oct; 212(2):543-7. PubMed ID: 20688329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men.
    Dallongeville J; Cottel D; Montaye M; Codron V; Amouyel P; Helbecque N
    Int J Cardiol; 2006 Jan; 106(2):152-6. PubMed ID: 16321685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.